-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Anixa Biosciences Inc quarterly/annual Revenues history and change rate from Q2 2016 to 2024.
- Anixa Biosciences Inc Revenues for the quarter ending 30 Apr 2023 was $210,000.000.
- Anixa Biosciences Inc annual Revenues for 2024 was $210,000.000, unchanged from 2023.
- Anixa Biosciences Inc annual Revenues for 2023 was $210,000.000.
- Anixa Biosciences Inc annual Revenues for 2021 was $512,000.000.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)